This panel session focused on FDA’s recent guidance and industry engagement on allergens, including the agency’s current thinking on labeling, enforcement, and thresholds, as well as provided insight on how global regulatory bodies are approaching allergen management. Attendees learned more about how the growing regulatory focus on allergens may have an impact on operations and also walked through how allergen risk assessments may be conducted for spices.

This session provided key updates on the latest trends in FDA import and facility inspections, entry review, sampling, and compliance expectations, along with practical guidance to help spice importers navigate inspections, avoid unnecessary delays, and streamline the import process.